|
HS Code |
944536 |
| Chemical Name | Trometamol |
| Synonyms | Tris, Tris base, Tris(hydroxymethyl)aminomethane |
| Molecular Formula | C4H11NO3 |
| Molecular Weight | 121.14 g/mol |
| Appearance | White crystalline powder |
| Solubility In Water | Very soluble |
| Ph Range | Approximately 10.4 (1M solution at 25°C) |
| Cas Number | 77-86-1 |
| Melting Point | 167-172°C |
| Usage | Buffering agent in biochemistry and pharmaceuticals |
As an accredited Trometamol factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
|
Purity 99%: Trometamol with purity 99% is used in biopharmaceutical formulations, where it ensures high buffer capacity and minimal contaminant interference. Buffer Capacity: Trometamol with high buffer capacity is used in cell culture media preparation, where it maintains precise pH stability during cell growth. Molecular Weight 121.14 g/mol: Trometamol with molecular weight 121.14 g/mol is used in intravenous solutions, where it enables accurate osmolarity control. pKa 8.1: Trometamol with pKa 8.1 is used in diagnostic reagent kits, where it provides optimal environment for enzymatic reactions. Melting Point 168–172°C: Trometamol with melting point 168–172°C is used in lyophilization processes, where it enhances product stability during freeze-drying. Low Endotoxin: Trometamol with low endotoxin levels is used in injectable drug formulations, where it reduces risk of pyrogenic responses. Particle Size <75 µm: Trometamol with particle size less than 75 µm is used in topical cream production, where it ensures homogeneous distribution and rapid dissolution. Stability Temperature up to 40°C: Trometamol stable up to 40°C is used in vaccine manufacturing, where it maintains formulation integrity during storage and transport. Solubility >100 g/L: Trometamol with solubility greater than 100 g/L is used in aqueous buffer preparation, where it facilitates rapid and complete dissolution. Non-hygroscopic: Trometamol with non-hygroscopic properties is used in solid pharmaceutical preparations, where it prevents moisture-induced degradation. |
| Packing | Trometamol is packaged in a 500g white HDPE bottle with a tamper-evident screw cap and clearly labeled safety and handling information. |
| Container Loading (20′ FCL) | Trometamol is typically shipped in 20′ FCLs, securely packed in drums or bags, ensuring moisture protection and efficient bulk transport. |
| Shipping | Trometamol should be shipped in tightly sealed containers made of compatible material, protected from moisture and contamination. During transport, it should be kept in a cool, dry place, away from incompatible substances. Follow all applicable local, national, and international regulations for transport and handling to ensure safety. |
| Storage | Trometamol should be stored in a tightly closed container in a cool, dry, and well-ventilated area, away from incompatible substances such as strong acids and oxidizing agents. It should be protected from light and moisture. Store at room temperature, typically between 15°C and 30°C. Always follow safety guidelines and use in accordance with relevant chemical handling protocols. |
| Shelf Life | Trometamol typically has a shelf life of 3–5 years when stored in tightly sealed containers at room temperature away from moisture. |
Competitive Trometamol prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to sales3@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: sales3@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Trometamol stands as a familiar presence in our daily routines here at the plant. Taking its technical name, 2-amino-2-(hydroxymethyl)-1,3-propanediol, we see it leave the reactors as a white crystalline solid. Most know it as TRIS or sometimes THAM. We start with high-purity feedstocks, tracking each step, watching for any signs of contamination or off-odor, since even slight impurities will show up down the line—whether in reactivity or during quality checks. Over years of manufacturing, you see how small process choices ripple through all the way to the forms and uses in pharmaceutical, biotech, diagnostics, and specialty chemical labs. Clients often ask for explanations about differences in specifications—why one batch’s pH is crucial for someone working with proteins, but another’s solubility profile matters for buffer making. The answer often comes down to foundational choices made before the product reaches the warehouse.
Each order for Trometamol begins by talking through exactly what the client hopes to do—molecular biology needs aren’t the same as clinical infusion solutions. Manufacturing realities shape the way we approach every grade, from reagent grade on up, and this is more than just what’s written on a certificate of analysis. For us, “pharmaceutical” means the plant’s operators check for endpoints by both titration and direct measurement, not because regulations demand it but because accumulated lessons have shown the blind spots in only using one analytical tool. The purest lots reach as high as 99.9% by HPLC, nailing down low levels of amines, acetaldehyde, and moisture. We’ve learned to hold tight controls over the water content, knowing labs using these buffers for sensitive tissue work will see impacts that can’t always be detected by a one-off specification check.
Back when we started, batches used to fluctuate by a few tenths of a percent. Early users would let us know if they saw cloudiness form or got curious results in high-sensitivity environments. Years of tweaking the process—changing reactor designs, tweaks to cooling rates, altered filtration—paid off. The process gets dialed in for every order going to diagnostic tool developers, or bulk shipments to pharmaceutical mixers, where even a hint of residual acidity or off-white color signals trouble. The most discerning labs want that assurance right from the production source. They don’t just want a COA—they want a history, and someone on the other end of the phone who’s seen the plant floors and knows how every release comes to be.
Every day, our tanks hold solutions of Trometamol in water, and shifts of workers inspect for clarity and pH. For those unfamiliar, TRIS isn’t just another buffering agent for biological or chemical systems. The role goes further: it helps maintain the environment that biological macromolecules—proteins, nucleic acids, enzymes—need to do their work. A stable environment, at the right pH, makes or breaks an experiment, especially at scale.
We’ve had visits from researchers who share stories of past sourcing complications: trace metals causing enzyme inhibition, organic byproducts affecting cell cultures, or inconsistent titration points hamstringing sensitive analyses. Our QC team listens, adjusts, and passes this on to the plant. Techniques like multi-step filtration and degassing dissolved gases have crossed over into our standard operation. Few things build trust faster than seeing technicians swab connections, verify seals, and repeat titration readings late into a shift. Those details matter—many customers tell us they can trace the moment their work began to run smoothly to their switch to a careful, steady supply straight from the production site.
Over the years, the market has seen waves of alternatives come and go—HEPES, MOPS, phosphate, and a string of others. At the plant, we’ve experimented with all of them for various custom applications, often with direct input from R&D. The biggest difference always comes back to three factors: interference, ease of preparation, and stability across temperature ranges. Trometamol wins in cases where enzyme systems, PCR, electrophoresis, or protein purification require minimal background reactivity or interference. Take phosphate buffers—common, cheap, but sometimes capable of reacting with metal ions or interfering with certain enzymatic reactions. Trometamol tends to leave a smaller background signal and avoids complexing with key cations, which makes it stand out in diagnostic kits or high-precision lab work.
For protein work, especially electrophoresis or chromatography, Trometamol brings another strength—stability near physiological pH. Many other buffers shift under changing temperatures or long-term storage. We’ve tracked the residual buffer stability during cold chain shipping or storage at elevated ambient temperatures. Our long-term data loggers have shown Trometamol holding steady where others have drifted by tenths of a pH unit. In side-by-side studies, labs have reported enzyme function and antibody stability carry through, batch after batch.
There are times where TRIS isn’t the right answer—strongly acidic or basic systems, for instance, are outside its optimal range. Other buffer agents beat Trometamol for pH below 6 or above 8.5. But every technician knows the familiar, smooth titration curve when reaching pH 7.4, practically embedded in the muscle memory of anyone who’s ever worked on a buffer bench.
Shipping bulk Trometamol carries its own quirks. Unlike some chemicals that pack loose and shift, Trometamol forms dense, tightly packed products—whether in fine powder, crystalline, or pre-dispersed liquid. The product absorbs water from the air, so every drum gets heat-sealed liners and is loaded quickly, especially during humid months. We avoid open air exposure, separating “open” lots from those locked down for medical applications. Storage isn’t particularly demanding, but a few years back, we had to re-engineer our packing line after a batch spent too long on a damp dock and picked up enough humidity to clump. Since then, fast turnover controls moisture content from factory floor to delivery. Many times, we get requests for immediate re-packing after spectrophotometry shows too much bound water.
Clients sometimes request pre-measured volumes or custom blends, especially for larger manufacturing runs. That’s where the experience in process engineering becomes real. Custom batch printing, automated blending, and tracked lot lineage all ensure no difference in product from the first kilogram to the last pallet, and our teams regularly walk clients through the process. We’ve even invited client QA teams right onto the floor for lot release sign-offs—nothing to hide behind glass walls when workers are confident in the process.
Much of the Trometamol produced here heads for buffer solutions used across molecular biology, PCR, Western blotting, and protein crystallization. We see another steady line headed to pharmaceuticals—especially IV injections where Trometamol stabilizes medications and holds pH in a physiologically safe range. Our lines have supported serum dialysis, mRNA vaccine stabilization, and cell-free genetic sequencing workflows that have become more standard in biotech pipelines. There’s satisfaction here, knowing what leaves our facility plays a part in life-saving and world-changing science, not just as a commodity, but as a critical ingredient whose purity means the difference between actionable data and an experiment gone off the rails.
Diagnostic manufacturers demand the tightest specs—trace metals below detection limits, no background UV absorbance, zero endotoxins. Achieving this takes more than just meeting a regulatory checklist. We go further, sometimes extending production time or running extra QC tests. Techs track environmental conditions, logging temperatures, filter integrity, and humidity so clients receive a narrative, not just a number. Bench scientists have told us how switching to our lot-stream TRIS cut down on noise in ELISA and PCR kits, where earlier lots from brokers with unknown provenance led to expensive troubleshooting and delayed development.
Long before a product ships, at least three operators will have inspected and signed off each batch. Whether the batch is destined for a protein kit in Boston or a pharmaceutical plant in Basel, batch records show all modification decisions. On one occasion, a minor fluctuation in supplied base caused a shift in endpoint during synthesis. Instead of sweeping the issue aside, teams held the batch, reran verification, and contacted the client about the delay and reason behind it. Later feedback confirmed that a less rigorous supplier had previously let variable TRIS through to a vaccine pilot run, producing inconsistent results and financial losses.
Each customer brings a slightly different set of expectations. Some labs want technical phone support at the time of buffer preparation—these users want certainty in how to dissolve, filtrate, and set the correct concentration, not a printed instruction. A team from an oncology research group called us out to walk through solubility tests on their own benches to verify dissolution rates and stability at their operational temperatures. Results lined up tightly, and their feedback prompted us to tweak particle size distribution further, improving batch-to-batch mixing speed for future runs. The real value in standing behind every batch extends beyond the paperwork—it’s in treating each lot as a partnership with the user.
Plenty of attention lands on the regulatory landscape. Trometamol destined for medical products prompts additional layers of oversight—not just by national health authorities, but also corporate auditors and internal review teams. We keep extensive records not only as legal requirements, but as a corporate habit. Any excursion from validated process immediately sparks an investigation—QC flags samples, production pauses, and every deviation gets documented and communicated. In the past, we’ve engaged directly alongside clients during FDA or EMA audits regarding batch provenance or analytical traceability. These meetings tend to run smoothly when we have the direct production history available, operator names signed off at every stage, and can walk through each release in sequence.
Those relying on Trometamol for regulated drug or device manufacture especially appreciate transparency. We understand the need does not end with COAs. Many users must submit full supporting documentation as part of market applications, and we back those requirements up with access to master batch records, ongoing method qualification, and even on-site process witness audits. Through repeated cycles of review and improvement, we continue to invest in upgrading batch record systems, further automating test traceability, and integrating process validation into daily routines. This delivers peace of mind for downstream users when regulatory deadlines approach.
Several chemical buffers compete in the same arena as Trometamol. HEPES, MOPS, and phosphate come up often in technical conversations, and after years of client reports and our own in-house use, some patterns keep recurring. HEPES provides high buffering capacity at pH 7.5, but any photoreactive or high-temperature work risks breakdown and unwanted byproducts. Phosphate runs into solubility and precipitation problems during complex biological manipulations, especially where divalent ions and chelators exist. In contrast, Trometamol’s chemical structure sidesteps metal interaction issues, and we routinely hear from researchers who switched over to preserve enzymes or antibodies during multi-step purifications.
One persistent myth is that buffer selection amounts to small technicalities. In fact, sensitive biological work often depends on these “minor” choices—a small impurity in TRIS may seem irrelevant to a chemical process but makes a world of difference in tissue or cell culture. We have documented cases where switching to Trometamol with certified low metal and amine content resulted in cleaner sequencing reads, sharper electrophoresis bands, and reductions in false positive diagnostic signals. These outcomes come not as luck, but from experience-backed process design and strict adherence to feedback-driven improvement.
Many times, the best technical leap comes not from within the plant, but from user feedback. We keep a rolling record of post-delivery comments—documenting not only validated specifications, but subtle differences: easier/Rapid dissolution, changes in odor, even operator impressions around flow rates for large-scale media preparation. Where comments line up around a recurring issue—batch clumping, slow blending, hints of color—we trace it back to raw material or process deviations and respond with changes both in batch controls and feedstock selection. This cycle of field-to-floor adjustment has improved shelf stability and mixing properties in ways difficult to predict in a closed R&D setting.
Case in point: a series of feedback signals from microfluidics startups running assays at scale suggested minor foam formation during rapid liquid handling. Plant teams collaborated with process engineers, narrowing potential causes to micro-particle content, and introduced additional filtration and controlled drying for affected lots. Several users confirmed improved reliability, showing that listening to the real workbench makes all the difference.
Supply chain integrity plays a decisive role lately, especially during recent disruptions to chemical logistics. Unlike commodity chemicals routed through brokers or traders, direct manufacturer supply builds in chain-of-custody security. Shipments from our loading dock show traceable stewardship—from receipt of raw material straight into controlled storage, through documented production, testing, and locked packaging. Users in R&D frequently bring up the value in being able to trace not only specifications, but actual production conditions and accountable handlers for every lot. When timelines and critical results matter, this full-chain transparency can mean projects remain on schedule, free from rogue batch discrepancies that have caused high-profile failures at other sites.
We have always aimed to minimize our impact up and down the line. Efficient water usage, solvent recovery, and energy monitoring remain part of daily operations—not out of box-ticking, but because chemical plants survive on tight margins, and waste equals cost. Process engineers frequently test new approaches for lower-emission drying and reclamation, and recent equipment upgrades have reduced solvent losses by half over prior years. The byproducts from Trometamol synthesis do not enter community water or air streams; instead, they move into treatment lines which further break them down or recover usable value. This approach helps both the community nearby and the bottom line. Feedback from surrounding neighborhood committees continues to shape our site practices, keeping us accountable not only to regulatory frameworks but also to those who live and work next to our operation.
The skill behind each batch of Trometamol runs deeper than machine calibrations or automated lines. Many of our operators have trained in the same plant for decades, seeing the material through multiple production eras—manual flask runs, semi-automated mixers, and now automated large-scale reactors. Still, every high-stakes batch sees an operator confirm results by smell, sight, and even touch—characteristics not captured in instrument printouts but learned through experience. These seasoned hands can tell if a lot requires another filtration step, if the drying went a bit too quickly, or if a subtle shift in a reagent threatens downstream stability. The difference, clients have reported, shows up in the results and the reduction in troubleshooting calls months after the fact.
We keep this human sense alive by mentoring new hires with experienced hands, letting them work side-by-side until they understand not just how, but why each process step matters. Annual reviews compare batch histories and encourage knowledge-sharing, bringing together feedback not just from clients, but from those working every day at the production site. By keeping both technical and practical experience close at hand, we reinforce the reputation for consistently delivering Trometamol that works as intended, whether in a biopharmaceutical line or a research bench pipette.
As demand for reliable and high-purity Trometamol grows, especially in advanced therapy and precision diagnostic applications, continuous investment in plant and process remains a top priority. Collaborating with users in fields as varied as cell therapy, genomics, and decentralized diagnostics drives our team to constantly evaluate performance, adjust output, and invest in new analytics. Recent years have brought requests for new certifications, even higher purity levels, and bespoke documentation for regulatory filings. Our production teams work closely with lab users to adapt, ensuring each new requirement not only gets met, but is directly integrated into process upgrades and training.
In the end, manufacturing Trometamol goes beyond reactors and control charts. It means treating every request as a technical partnership. Anchored in a culture shaped by operator skill, technical transparency, and willingness to respond to feedback, this approach delivers reliable, trusted Trometamol—a difference that shows up not just in test results, but in the day-to-day successes of those who rely on it. Our commitment is to keep these standards improving, adapting with every shift and every shared insight from the field.